Zhukai Cong

Dr. Zhukai Cong

Peking University Third Hospital
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2020 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
DLDan Li
Dan Li
ZCZhukai Cong
Zhukai Cong
CYCui Yang
Cui Yang
XZXi Zhu
Xi Zhu

27 December 2022 in Journal of Personalized Medicine
Verified
Journal Article
Open access
PDF file
XCXiao Cui
Xiao Cui
YCYundi Chang
Yundi Chang
CYCui Yang
Cui Yang
ZCZhukai Cong
Zhukai Cong
BWBaocheng Wang
Baocheng Wang
YLYUXIN LENG
YUXIN LENG
Background: The intensive care unit is a center for massive data collection, making it the best field to embrace big data and artificial intelligence. Objective: This study aimed to provide a literature overview on the development of artificial intelligence in critical care medicine (CCM) and tried to give valuable information about further precision medicine. Methods: Relevant studies published between January 2010 and June 2021 were manually retrieved from the Science Citation Index Expanded database in Web of Science (Clarivate), using keywords. Results: Research related to artificial intelligence in CCM has been increasing over the years. The USA published the most articles and had the top 10 active affiliations. The top ten active journals are bioinformatics journals and are in JCR Q1. Prediction, diagnosis, and treatment strategy exploration of sepsis, pneumonia, and acute kidney injury were the most focused topics. Electronic health records (EHRs) were the most widely used data and the “-omics” data should be integrated further. Conclusions: Artificial intelligence in CCM has developed over the past decade. With the introduction of constantly growing data volume and novel data types, more investigation on artificial intelligence ethics and model correctness and extrapolation should be performed for generalization.

31 January 2020 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
ZCZhukai Cong
Zhukai Cong
DLDan Li
Dan Li
YTYifan Tao
Yifan Tao
XLXiangpeng Lv
Xiangpeng Lv
XZXi Zhu
Xi Zhu

23 July 2020 in Clinical Science
Verified
Journal Article
Open access
PDF file
ZCZhukai Cong
Zhukai Cong
DLDan Li
Dan Li
XLXiangpeng Lv
Xiangpeng Lv
CYCui Yang
Cui Yang
QZQiang Zhang
Qiang Zhang
XZXi Zhu
Xi Zhu
Acute respiratory distress syndrome (ARDS) is a severe condition with high morbidity and mortality and few interventions. The role of sympathetic stress in the pathogenesis of ARDS has attracted recent research attention. Blockade of α-2 or α2A-adrenoceptor (α2A-AR) has been shown to attenuate lung injury induced by lipopolysaccharide (LPS) in rats. However, the mechanism is unclear. We confirmed the role of α2A-AR in ARDS using knockout mice and alveolar macrophages following LPS stimulation to assess the underlying mechanisms. We found that α2A-AR deficiency decreased the permeability of the alveolar capillary barrier in ARDS mice and suppressed lung inflammation by reducing inflammatory cell infiltration and the production of TNF-α, interleukin (IL)-6, and CXCL2/MIP-2. LPS stimulation decreased NF-κB activation in lung tissues of α2A-AR deficient mice and increased norepinephrine concentrations. In vitro, we found that norepinephrine inhibited the production of TNF-α, IL-6, and CXCL2/MIP-2 and promoted the secretion of IL-10 from LPS-stimulated murine alveolar macrophages. Blockade of α2A-AR by a specific antagonist further inhibited the production of TNF-α, IL-6, and IL-10. Furthermore, norepinephrine down-regulated NF-κB activation in stimulated alveolar macrophages. Altogether, these results suggest that α2A-AR deficiency ameliorates lung injury by increasing norepinephrine concentrations in lung tissues and inhibiting the activation of alveolar macrophages.

10 April 2024 in Research Square
Verified
Preprint
Open access
PDF file
SWSenhao Wei
Senhao Wei
HZHua Zhang
Hua Zhang
HLHao Li
Hao Li
CLChao Li
Chao Li
ZSZiyuan Shen
Ziyuan Shen
XZXi Zhu
Xi Zhu
Background: Acute respiratory distress syndrome (ARDS) is a prevalent complication among critically ill patients, constituting around 10% of intensive care unit (ICU) admissions and mortality rates ranging from 35% to 46%. Hence, early recognition and prediction of ARDS are crucial for the timely administration of targeted treatment. However, ARDS is frequently underdiagnosed or delayed, and its heterogeneity diminishes the clinical utility of ARDS biomarkers. This study aimed to observe the incidence of ARDS among high-risk patients and develop and validate an ARDS prediction model using machine learning (ML) techniques based on clinical parameters. Methods: This prospective cohort study in China was conducted on critically ill patients to derivate and validate the prediction model. The derivation cohort, consisting of 400 patients admitted to the ICU of the Peking University Third Hospital(PUTH) between December 2020 and August 2023, was separated for training and internal validation, and an external data set of 160 patients at the FU YANG People's Hospital from August 2022 to August 2023 was employed for external validation. Least absolute shrinkage and selection operator (LASSO) and multivariate logistic regression were used to screen predictor variables. Multiple ML classification models were integrated to analyze and identify the best models. Several evaluation indexes were used to compare the predictive performance, including the area under the receiver-operating-characteristic curve (AUC) and decision curve analysis (DCA). S Hapley Additive ex Planations (SHAP) is used to interpret ML models. Results:400 critically ill patients were included in the analysis, with 117 developing ARDS during follow-up. The final model included gender, Lung Injury Prediction Score (LIPS), HepaticDisease, Shock, and combined Lung Contusion. Based on the AUC and DCA in the validation group, the logistic model demonstrated excellent performance, achieving an AUC of 0.836 (95% CI: 0.762-0.910). For external validation, comprising 160 patients, 44 of whom developed ARDS, the AUC was 0.799 (95% CI: 0.723-0.875). conclusion: Logistic regression models were constructed and interpreted using the SHAP method to provide a basis for screening high-risk groups for ARDS and to guide individualized treatment for different patients.